5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.08▲ | 1.09▼ | 1.09▼ | 1.12▼ | 1.14▼ |
MA10 | 1.09▼ | 1.10▼ | 1.10▼ | 1.18▼ | 1.05▲ |
MA20 | 1.11▼ | 1.15▼ | 1.15▼ | 1.12▼ | 0.88▲ |
MA50 | 1.17▼ | 1.13▼ | 1.13▼ | 1.05▲ | 1.62▼ |
MA100 | 1.12▼ | 1.10▼ | 1.13▼ | 0.85▲ | 2.24▼ |
MA200 | 1.13▼ | 1.21▼ | 1.11▼ | 1.42▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.011▼ | -0.011▼ | -0.015▼ | 0.102▲ |
RSI | 42.547▼ | 42.966▼ | 43.105▼ | 47.508▼ | 47.775▼ |
STOCH | 20.536 | 33.780 | 33.780 | 38.104 | 42.740 |
WILL %R | -68.750 | -82.143▼ | -82.143▼ | -75.806▼ | -59.095 |
CCI | -43.545 | -52.146 | -52.146 | -56.453 | 33.119 |
Tuesday, May 14, 2024 05:00 PM
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
|
Tuesday, May 14, 2024 02:54 PM
XLO stock results show that Xilio Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never ...
|
Tuesday, May 14, 2024 05:08 AM
Expect to initiate Phase 2 trial for XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 1.085 | 1.11 | 1.06 | 1.085 | 222,772 |
15/05/24 | 1.09 | 1.15 | 1.09 | 1.12 | 117,414 |
14/05/24 | 1.06 | 1.14 | 1.06 | 1.09 | 125,287 |
13/05/24 | 1.08 | 1.125 | 1.08 | 1.125 | 273,372 |
10/05/24 | 1.30 | 1.30 | 1.11 | 1.18 | 229,361 |
09/05/24 | 1.21 | 1.32 | 1.16 | 1.26 | 217,100 |
08/05/24 | 1.29 | 1.29 | 1.16 | 1.21 | 157,582 |
07/05/24 | 1.26 | 1.29 | 1.25 | 1.26 | 97,764 |
06/05/24 | 1.19 | 1.28 | 1.18 | 1.25 | 284,782 |
03/05/24 | 1.06 | 1.2199 | 1.04 | 1.18 | 264,885 |
|
|
||||
|
|
||||
|
|